A new trading day began on Monday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price up 5.61% from the previous day of trading, before settling in for the closing price of $10.33. ADPT’s price has ranged from $3.85 to $12.43 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.51%. Meanwhile, its annual earnings per share averaged 21.53%. With a float of $144.91 million, this company’s outstanding shares have now reached $151.92 million.
Considering the fact that the conglomerate employs 619 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 61.06%, operating margin of -71.5%, and the pretax margin is -74.86%.
Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 4.61%, while institutional ownership is 89.60%. The most recent insider transaction that took place on May 16 ’25, was worth 17,149. In this transaction Chief Financial Officer of this company sold 1,929 shares at a rate of $8.89, taking the stock ownership to the 277,396 shares. Before that another transaction happened on May 01 ’25, when Company’s Chief Scientific Officer sold 68,412 for $7.35, making the entire transaction worth $502,828. This insider now owns 1,279,524 shares in total.
Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.19% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.64 in one year’s time.
